Atlas Trials

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019(COVID-19)Pneumonia

Clinical trial NCT04880694 · COMPLETED

Trial details

NCT number
NCT04880694
Sponsor
Grand Medical Pty Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe COVID-19 Pneumonia
Start date
2021-05-20
Primary completion
2022-01-07
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.